Improved 3D-QSAR prediction by multiple-conformational alignment: A case study on PTP1B inhibitors

Three-dimension quantitative structure activity relationship (3D-QSAR) was one of the major statistical techniques to investigate the correlation of biological activity with structural properties of candidate molecules, and the accuracy of statistic greatly depended on molecular alignment methodology. Exhaustive conformational search and successful conformational superposition could extremely improve the predictive accuracy of QSAR modeling. In this work, we proposed a solution to optimize QSAR prediction by multiple-conformational alignment methods, with a set of 40 flexible PTP1B inhibitors as case study. Three different molecular alignment methods were used for the development of 3D-QSAR models listed as following: (1) docking-based alignment (DBA); (2) pharmacophore-based alignment (PBA) and (3) co-crystallized conformer-based alignment (CCBA). Among these three alignments, it was indicated that the CCBA was the best and the fastest strategy in 3D-QSAR development, with the square correlation coefficient (r2) and cross-validated squared correlation coefficient (q2) of comparative molecular field analysis (CoMFA) were 0.992 and 0.694; the r2 and q2 of comparative molecular similarity indices analysis (CoMSIA) were 0.972 and 0.603, respectively. The alignment methodologies used here not only generated a robust QSAR model with useful molecular field contour maps for designing novel PTP1B inhibitors, but also provided a solution for constructing accurate 3D-QSAR model for various disease targets. Undoubtedly, such attempt in QSAR analysis would greatly help us to understand essential structural features of inhibitors required by its target, and so as to discover more promising chemical derivatives.

[1]  G R Marshall,et al.  3D-QSAR: a current perspective. , 1995, Trends in pharmacological sciences.

[2]  Durg Vijay Singh,et al.  In silico modelling and molecular dynamics simulation studies of thiazolidine based PTP1B inhibitors , 2018, Journal of biomolecular structure & dynamics.

[3]  W. Welsh,et al.  Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a "divide and conquer" strategy. , 2001, Journal of medicinal chemistry.

[4]  Alexander Tropsha,et al.  Best Practices for QSAR Model Development, Validation, and Exploitation , 2010, Molecular informatics.

[5]  A. Moretto,et al.  Structure-based optimization of protein tyrosine phosphatase 1B inhibitors: from the active site to the second phosphotyrosine binding site. , 2007, Journal of medicinal chemistry.

[6]  J. Dearden,et al.  QSAR modeling: where have you been? Where are you going to? , 2014, Journal of medicinal chemistry.

[7]  Javier Martínez-Salazar,et al.  3D-QSAR as a Tool for Understanding and Improving Single-Site Polymerization Catalysts. A Review , 2014 .

[8]  Gyanendra Pandey,et al.  3D QSAR Studies on Protein Tyrosine Phosphatase 1B Inhibitors: Comparison of the Quality and Predictivity among 3D QSAR Models Obtained from Different Conformer-Based Alignments , 2006, J. Chem. Inf. Model..

[9]  Young-Bum Kim,et al.  Increased Energy Expenditure, Decreased Adiposity, and Tissue-Specific Insulin Sensitivity in Protein-Tyrosine Phosphatase 1B-Deficient Mice , 2000, Molecular and Cellular Biology.

[10]  C. Hansch,et al.  p-σ-π Analysis. A Method for the Correlation of Biological Activity and Chemical Structure , 1964 .

[11]  Reaz Uddin,et al.  Development of robust QSAR model using rapid overlay of crystal structures (ROCS) based alignment: a test case of Tubulin inhibitors , 2012, Medicinal Chemistry Research.

[12]  Wei Li,et al.  Evaluation of licorice flavonoids as protein tyrosine phosphatase 1B inhibitors. , 2013, Bioorganic & medicinal chemistry letters.

[13]  Andrea Armirotti,et al.  Design, Synthesis, Structure-Activity Relationship Studies, and Three-Dimensional Quantitative Structure-Activity Relationship (3D-QSAR) Modeling of a Series of O-Biphenyl Carbamates as Dual Modulators of Dopamine D3 Receptor and Fatty Acid Amide Hydrolase. , 2017, Journal of medicinal chemistry.

[14]  Zhen Xu,et al.  Computational Insight into p21‐Activated Kinase 4 Inhibition: A Combined Ligand‐ and Structure‐Based Approach , 2014, ChemMedChem.

[15]  Sarath Kumar Baskaran,et al.  Molecular Dynamics Approach to Probe the Allosteric Inhibition of PTP1B by Chlorogenic and Cichoric Acid , 2012, J. Chem. Inf. Model..

[16]  Matthew P. Repasky,et al.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. , 2006, Journal of medicinal chemistry.

[17]  Gang Liu,et al.  Isoxazole carboxylic acids as protein tyrosine phosphatase 1B (PTP1B) inhibitors. , 2004, Bioorganic & medicinal chemistry letters.

[18]  Tim Cheeseright,et al.  Molecular field technology applied to virtual screening and finding the bioactive conformation , 2007, Expert opinion on drug discovery.

[19]  Rajendra Kumar,et al.  Probing Interaction Requirements in PTP1B Inhibitors: A Comparative Molecular Dynamics Study , 2010, J. Chem. Inf. Model..

[20]  Glen E Kellogg,et al.  How to deal with low-resolution target structures: using SAR, ensemble docking, hydropathic analysis, and 3D-QSAR to definitively map the αβ-tubulin colchicine site. , 2013, Journal of medicinal chemistry.

[21]  K. Nikolić,et al.  QSAR studies and design of new analogs of vitamin E with enhanced antiproliferative activity on MCF-7 breast cancer cells , 2016 .

[22]  B. Min,et al.  Protein tyrosine phosphatase 1B (PTP1B) inhibitory activity and glucosidase inhibitory activity of compounds isolated from Agrimonia pilosa , 2016, Pharmaceutical biology.

[23]  Mao-Sheng Cheng,et al.  In Silico Design of Human IMPDH Inhibitors Using Pharmacophore Mapping and Molecular Docking Approaches , 2015, Comput. Math. Methods Medicine.